List view / Grid view
23 April 2015 | By Victoria White
Bayer and UKE are the main coordinators of a new international consortium, CANCER-ID, to develop novel blood-based biomarker technologies in cancer...
23 April 2015 | By Victoria White
Cytori Therapeutics presented data from two preclinical studies at ABA2015. The findings provide greater detail on Cytori's cell therapies...
23 April 2015 | By Victoria White
Dimension Therapeutics is advancing programmes to treat two rare diseases with often devastating outcomes for patients - OTC deficiency and GSDIa...
23 April 2015 | By Victoria White
An article describing an important scientific foundation for the clinical development of truly personalised cancer immunotherapies has been published...
22 April 2015 | By Victoria White
New preclinical data demonstrates that mAbXcite therapies causes an immune cascade that successfully recruits T-cells to mount an attack against cancer...
22 April 2015 | By Victoria White
Blend Therapeutics has presented preclinical data on it's lead product candidate, BTP-114, a novel personalised cisplatin prodrug, at AACR 2015...
22 April 2015 | By Victoria White
ARIAD has announced the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor, brigatinib (AP26113), at AACR 2015...
22 April 2015 | By Victoria White
Astellas and Potenza have entered an exclusive R&D collaboration. The agreement includes an option for the future acquisition of Potenza by Astellas...
21 April 2015 | By Victoria White
Epizyme has presented data on two epigenetic targets, CARM1 and PRMT6, in its pioneering therapeutic pipeline at the AACR Annual Meeting 2015...
21 April 2015 | By Victoria White
Men with prostate cancer benefit from treatment with the pioneering drug olaparib according to the results of a major trial presented today...
21 April 2015 | By Victoria White
MaxCyte and Johns Hopkins University to collaborate to develop unique CAR T-cell therapies which harness patients’ own immune systems to combat cancers...
21 April 2015 | By Victoria White
Transgene has announced that new preclinical data for two of its programmes – TG4010 and TG3003 – were presented at the Annual Meeting of the AACR...
21 April 2015 | By Victoria White
The first patient enrolled in a Phase I clinical trial evaluating the safety and feasibility of NKG2D CAR T-cell therapy has been infused...
21 April 2015 | By Victoria White
MRC Technology, an independent life science medical research charity, has appointed Andrew Mercieca as its Finance Director from 1 April 2015...
20 April 2015 | By Victoria White
Results from a preclinical study of AV-380, a GDF15 inhibitory antibody for the treatment of cancer associated cachexia, have been presented at AACR 2015...
